Literature DB >> 33825946

Localized ALK-positive histiocytosis in a Chinese woman: report of a case in the lung with a novel EML4-ALK rearrangement.

Yanhua Bai1, Wei Sun1, Dongfeng Niu1, Xin Yang1, Xinting Diao1, Yang Yu2, Dongmei Lin3.   

Abstract

ALK-positive histiocytosis (APH) is a newly defined entity with specific histological features and a highly recurrent KIF5B-ALK gene fusion. APH is characterized by clonal proliferation of histiocytes and can present as either systemic or localized. It was first described in infants and then expanded to older children and adults. Although lung involvement has been shown in three systemic cases, localized lung lesions have not previously been reported. The ALK gene has many fusion partners in addition to KIF5B in APH. Here, we report a striking case of localized APH in the lung harboring a rare EML4-ALK rearrangement in a 52-year-old Chinese woman. Furthermore, we reviewed the previously published APH cases, analyzed the partner genes of the ALK fusions, and explored the role of patient ethnicity. We discovered a link between ethnicity and this rare disease.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  ALK; CD163; CD68; EML4; Histiocytosis

Mesh:

Substances:

Year:  2021        PMID: 33825946     DOI: 10.1007/s00428-021-03092-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  12 in total

1.  ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female.

Authors:  Gaurav K Gupta; Liqiang Xi; Svetlana D Pack; Jennifer B Jones; Stefania Pittaluga; Mark Raffeld; Elaine S Jaffe
Journal:  Haematologica       Date:  2019-08-01       Impact factor: 9.941

2.  ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion.

Authors:  Kenneth Tou En Chang; Amos Zhi En Tay; Chik Hong Kuick; Huiyi Chen; Elizabeth Algar; Nadine Taubenheim; Janine Campbell; Francoise Mechinaud; Martin Campbell; Leanne Super; Chavit Chantranuwat; S T Yuen; John K C Chan; Chung W Chow
Journal:  Mod Pathol       Date:  2018-12-20       Impact factor: 7.842

3.  ALK-positive histiocytosis with KIF5B-ALK fusion in the central nervous system.

Authors:  Calixto-Hope G Lucas; Ahmed Gilani; David A Solomon; Xiayuan Liang; Ossama M Maher; Gabriel Chamyan; Bette K Kleinschmidt-Demasters; Arie Perry
Journal:  Acta Neuropathol       Date:  2019-05-22       Impact factor: 17.088

4.  ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology.

Authors:  Jumpei Kashima; Masayuki Yoshida; Kenjiro Jimbo; Koji Izutsu; Tetsuo Ushiku; Kan Yonemori; Akihiko Yoshida
Journal:  Am J Surg Pathol       Date:  2021-03-01       Impact factor: 6.394

5.  ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.

Authors:  John K C Chan; Laurence Lamant; Elizabeth Algar; Georges Delsol; William Y W Tsang; King C Lee; Karin Tiedemann; Chung W Chow
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

6.  Large-scale screening and molecular characterization of EML4-ALK fusion variants in archival non-small-cell lung cancer tumor specimens using quantitative reverse transcription polymerase chain reaction assays.

Authors:  Tianhong Li; Martin K H Maus; Sonal J Desai; Laurel A Beckett; Craig Stephens; Eric Huang; Jack Hsiang; Gary Zeger; Kathleen D Danenberg; Stephanie H Astrow; David R Gandara
Journal:  J Thorac Oncol       Date:  2014-01       Impact factor: 15.609

7.  ALK Fusions in a Wide Variety of Tumor Types Respond to Anti-ALK Targeted Therapy.

Authors:  Jeffrey S Ross; Siraj M Ali; Omotayo Fasan; Jared Block; Sumanta Pal; Julia A Elvin; Alexa B Schrock; James Suh; Sahar Nozad; Sungeun Kim; Hwa Jeong Lee; Christine E Sheehan; David M Jones; Jo-Anne Vergilio; Shakti Ramkissoon; Eric Severson; Sugganth Daniel; David Fabrizio; Garrett Frampton; Vince A Miller; Philip J Stephens; Laurie M Gay
Journal:  Oncologist       Date:  2017-10-27

8.  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms.

Authors:  Eli L Diamond; Benjamin H Durham; Julien Haroche; Zhan Yao; Jing Ma; Sameer A Parikh; Zhaoming Wang; John Choi; Eunhee Kim; Fleur Cohen-Aubart; Stanley Chun-Wei Lee; Yijun Gao; Jean-Baptiste Micol; Patrick Campbell; Michael P Walsh; Brooke Sylvester; Igor Dolgalev; Olga Aminova; Adriana Heguy; Paul Zappile; Joy Nakitandwe; Chezi Ganzel; James D Dalton; David W Ellison; Juvianee Estrada-Veras; Mario Lacouture; William A Gahl; Philip J Stephens; Vincent A Miller; Jeffrey S Ross; Siraj M Ali; Samuel R Briggs; Omotayo Fasan; Jared Block; Sebastien Héritier; Jean Donadieu; David B Solit; David M Hyman; José Baselga; Filip Janku; Barry S Taylor; Christopher Y Park; Zahir Amoura; Ahmet Dogan; Jean-Francois Emile; Neal Rosen; Tanja A Gruber; Omar Abdel-Wahab
Journal:  Cancer Discov       Date:  2015-11-13       Impact factor: 39.397

9.  Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.

Authors:  Ankush Bhatia; Vaios Hatzoglou; Gary Ulaner; Raajit Rampal; David M Hyman; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Mariko Yabe; Kseniya Petrova-Drus; Katherine S Panageas; Anne Reiner; Marc Rosenblum; Eli L Diamond
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

10.  ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib.

Authors:  Charlotte Syrykh; Loïc Ysebaert; Sarah Péricart; Solène M Evrard; Fabienne Meggetto; Salim Kanoun; Pierre Brousset; Camille Laurent
Journal:  Virchows Arch       Date:  2020-10-03       Impact factor: 4.064

View more
  3 in total

1.  Case Report: Rare Systemic and Aggressive ALK-Positive Histiocytosis With Recurrent Pancreatitis Treating by Alectinib.

Authors:  Yanchu Li; Changle Shi; Yu Wu; Mingmin He; Xueming Xia; Jie Liu; Yu Jiang
Journal:  Front Med (Lausanne)       Date:  2022-05-19

Review 2.  Failure of crizotinib based systemic treatment in ALK positive histiocytosis involving the central nervous system: a case report and literature review.

Authors:  Qiang He; Wenjie Zhang; Qiang Li
Journal:  BMC Pediatr       Date:  2022-05-25       Impact factor: 2.567

3.  ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Authors:  Paul G Kemps; Jennifer Picarsic; Benjamin H Durham; Zofia Hélias-Rodzewicz; Laura Hiemcke-Jiwa; Cor van den Bos; Marianne D van de Wetering; Carel J M van Noesel; Jan A M van Laar; Robert M Verdijk; Uta E Flucke; Pancras C W Hogendoorn; F J Sherida H Woei-A-Jin; Raf Sciot; Andreas Beilken; Friedrich Feuerhake; Martin Ebinger; Robert Möhle; Falko Fend; Antje Bornemann; Verena Wiegering; Karen Ernestus; Tina Méry; Olga Gryniewicz-Kwiatkowska; Bozenna Dembowska-Baginska; Dmitry A Evseev; Vsevolod Potapenko; Vadim V Baykov; Stefania Gaspari; Sabrina Rossi; Marco Gessi; Gianpiero Tamburrini; Sébastien Héritier; Jean Donadieu; Jacinthe Bonneau-Lagacherie; Claire Lamaison; Laure Farnault; Sylvie Fraitag; Marie-Laure Jullié; Julien Haroche; Matthew Collin; Jackie Allotey; Majid Madni; Kerry Turner; Susan Picton; Pasquale M Barbaro; Alysa Poulin; Ingrid S Tam; Dina El Demellawy; Brianna Empringham; James A Whitlock; Aditya Raghunathan; Amy A Swanson; Mariko Suchi; Jon M Brandt; Nabeel R Yaseen; Joanna L Weinstein; Irem Eldem; Bryan A Sisk; Vaishnavi Sridhar; Mandy Atkinson; Lucas R Massoth; Jason L Hornick; Sanda Alexandrescu; Kee Kiat Yeo; Kseniya Petrova-Drus; Stephen Z Peeke; Laura S Muñoz-Arcos; Daniel G Leino; David D Grier; Robert Lorsbach; Somak Roy; Ashish R Kumar; Shipra Garg; Nishant Tiwari; Kristian T Schafernak; Michael M Henry; Astrid G S van Halteren; Oussama Abla; Eli L Diamond; Jean-François Emile
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.